In Vitro Synergy Testing of Anidulafungin with Itraconazole, Voriconazole, and Amphotericin B against Aspergillus spp. and Fusarium spp-Reference-Cited by-同舟云学术

In Vitro Synergy Testing of Anidulafungin with Itraconazole, Voriconazole, and Amphotericin B against Aspergillus spp. and Fusarium spp

Published:2005-08 Issue:8 Volume:49 Page:3572-3574
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Philip Annie¹,Odabasi Zekaver¹,Rodriguez Jose¹,Paetznick Victor L.¹,Chen Enuo¹,Rex John H.¹,Ostrosky-Zeichner Luis¹

Affiliation:

1. Laboratory of Mycology Research, Division of Infectious Diseases, University of Texas-Houston Medical School, Houston, Texas 77030

Abstract

ABSTRACT The in vitro interactions of anidulafungin with itraconazole, voriconazole, and amphotericin B were evaluated by using the checkerboard method. For Aspergillus spp., anidulafungin with amphotericin B showed indifference for 16/26 isolates, while anidulafungin with either azole showed a synergy trend for 18/26 isolates. All drug combinations showed indifference for 7/7 Fusarium sp. isolates.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.49.8.3572-3574.2005

Reference21 articles.

1. Agents Chemother. 2004 48

2. In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium spp

3. Carrillo-Munoz, A. J., M. Ruesga, S. Brio, O. del Valle, V. Rodriguez, P. Santos, J. M. Hernandez-Molina, E. Canton, J. Peman, J. Guarro, and G. Quindos. 2002. Comparison of in vitro antifungal activities of amphotericin B lipid complex with itraconazole against 708 clinical yeast isolates and opportunistic moulds determined by National Committee for Clinical Laboratory Standards methods M27-A and M38-P. Chemotherapy48:224-231.

4. Cornely, O. A., K. Schmitz, and S. Aisenbrey. 2002. The first echinocandin: caspofungin. Mycoses45(Suppl. 3):56-60.

5. Denning, D. W., P. Ribaud, N. Milpied, D. Caillot, R. Herbrecht, E. Thiel, A. Haas, M. Ruhnke, and H. Lode. 2002. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin. Infect. Dis.34:563-571.

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAF to the rescue! Potential and challenges of combination antifungal therapy for reducing morbidity and mortality in hospitalized patients with serious fungal infections;2024-07-11

2. In vitro and in vivo evaluation of antifungal combinations against azole-resistant Aspergillus fumigatus isolates;Frontiers in Cellular and Infection Microbiology;2023-01-17

3. In vitro antifungal susceptibility of Fusarium species and Aspergillus fumigatus cultured from eleven horses with fungal keratitis;Veterinary Ophthalmology;2022-06-09

4. Future Directions in the Management of Rhino-Orbito-Cerebral Mucormycosis;Rhino-Orbito-Cerebral Mucormycosis;2022

5. In vivo synergism of free miltefosine or in alginate-based nanocarrier combined with voriconazole on aspergillosis;Future Microbiology;2021-10